Balentine LLC’s Omega Healthcare OHI Stock Holding History

Balentine LLC’s Portfolio OHI Stock Details OHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-181	Closed	-$5K	–	638
2020 Q2	$5K	Buy	+181	New	+$5.36K	﹤0.01%	735

Other funds holding OHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Balentine LLC's OHI Position: Q3 2020 in Review

Balentine LLC sold out of Omega Healthcare (OHI) in Q3 2020, closing a stake of 181 shares — an estimated $5K sold.

Balentine LLC first reported a position in OHI in Q2 2020 and held it in 1 quarter. The position peaked at $5K in Q2 2020. 470 funds tracked by Wall St. Rank hold OHI as of Q3 2020.

Balentine LLC reported no remaining Omega Healthcare position as of Q3 2020 after selling out during the quarter.
Balentine LLC sold 181 Omega Healthcare shares in Q3 2020, an estimated $5K.
Balentine LLC first reported a position in Omega Healthcare in Q2 2020 and held it in 1 quarter.
Balentine LLC's Omega Healthcare position peaked at $5K in Q2 2020.
470 funds tracked by Wall St. Rank held Omega Healthcare as of Q3 2020.

Based on Balentine LLC's 13F filing for Q3 2020, filed 2 Nov 2020.